misonidazole has been researched along with Cancer of Oropharnyx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baxi, S; Beattie, B; Boyle, J; Chan, S; Ganly, I; Humm, J; Katabi, N; Lanning, R; Lee, N; Li, D; McBride, S; Mitrani, L; Morris, LG; Pfister, DG; Riaz, N; Schoder, H; Sherman, E; Wong, R; Yarusi, B; Zhang, Z | 1 |
| Chan, K; Fury, M; Humm, J; Lee, N; Ling, CC; Nehmeh, S; Schöder, H | 1 |
1 trial(s) available for misonidazole and Cancer of Oropharnyx
| Article | Year |
|---|---|
Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma.
Topics: Adult; Aged; Carcinoma; Chemoradiotherapy; Female; Humans; Male; Middle Aged; Misonidazole; Oropharyngeal Neoplasms; Oxygen; Positron-Emission Tomography; Radiation Protection; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Image-Guided; Treatment Outcome; Tumor Hypoxia | 2016 |
1 other study(ies) available for misonidazole and Cancer of Oropharnyx
| Article | Year |
|---|---|
Prospective trial incorporating pre-/mid-treatment [18F]-misonidazole positron emission tomography for head-and-neck cancer patients undergoing concurrent chemoradiotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cell Hypoxia; Cisplatin; Combined Modality Therapy; Fluorouracil; Humans; Laryngeal Neoplasms; Middle Aged; Misonidazole; Oropharyngeal Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed; Tumor Burden | 2009 |